HM-43239 Uses, Dosage, Side Effects and more
HM-43239 is under investigation in clinical trial NCT03850574 (Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
| Attribute | Details |
|---|---|
| Trade Name | HM-43239 |
| Generic | HM-43239 |
| Type | |
| Formula | C29H33ClN6 |
| Weight | Average: 501.08 Monoisotopic: 500.2455228 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
